XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($)
12 Months Ended
Oct. 31, 2016
Oct. 31, 2015
Research and Development Expense [Member]    
Non-cash Stock Option Compensation Expenses $ 259,930 $ 306,584
Selling and Marketing Expense [Member]    
Non-cash Stock Option Compensation Expenses $ 613,631 $ 2,369,806